Nov 6 (Reuters) -
EPS CO LTD
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to Six months to
Sep 30, 2009 Sep 30, 2008 Sep 30, 2010 Mar 31, 2010
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECASTS H1 FORECASTS
Sales 23.57 21.18 29.44 13.96
(+11.3 pct) (+17.8 pct) (+24.9%) (+19.4%)
Operating 4.01 3.49 4.22 1.70
(+14.9 pct) (+17.0 pct) (+5.3%) (-13.3%)
Recurring 4.05 3.56 4.25 1.71
(+13.7 pct) (+17.1 pct) (+4.8%) (-13.4%)
Net 1.71 1.71 2.07 859 mln
(+0.3 pct) (+23.4 pct) (+20.8%) (+53.1%)
EPS Y19,162.75 Y19,110.92 Y23,162.39 Y9,618.21
Diluted
EPS Y19,149.73 Y19,074.29
Annual div Y6,000.00 Y5,400.00 Y6,600.00
-Q2 div Y2,800.00 Y2,400.00 Y3,200.00
-Q4 div Y3,200.00 Y3,000.00 Y3,400.00
NOTE - EPS Co Ltd conducts clinical trials for pharmaceutical makers.
For latest earnings estimates made by Toyo Keizai, please
double click on 4282.TK1.